MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RUBIN, R. P.
Right arrow Articles by FREER, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RUBIN, R. P.
Right arrow Articles by FREER, R. J.

Molecular Pharmacology, Vol 19, 31-37, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

On the Relationship between Formylmethionyl-Leucyl-Phenylalanine Stimulation of Arachidonyl Phosphatidylinositol Turnover and Lysosomal Enzyme Secretion by Rabbit Neutrophils

RONALD P. RUBIN 1, LYNN E. SINK 1, and RICHARD J. FREER 1

1 Department of Pharmacology, Medical College of Virginia, Richmond, Virginia 23298

The addition of the synthetic chemotactic peptide formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe) to rabbit neutrophils promoted [14C]arachidonic acid incorporation into phosphatidylinositol and lysosomal enzyme release; these two processes increased in parallel with respect to time and peptide concentration and were dependent upon extracellular Ca2+. Cytochalasin B, which augments enzyme release, also enhanced fMet-Leu-Phe-evoked arachidonyl phosphatidylinositol turnover. The peptide did not alter the incorporation of labeled palmitic acid or glycerol into phosphatidylinositol, although 32P turnover was increased within 2 min. Another synthetic peptide, methionyl-leucyl-phenylalanine, failed to enhance arachidonic acid incorporation into phosphatidylinositol and was unable to promote lysosomal enzyme secretion. These results support the hypothesis that fMet-Leu-Phe-induced stimulation of lysosomal enzyme release and Ca2+-dependent turnover of arachidonyl phosphatidylinositol are somehow related. These findings, taken together with our previous studies demonstrating similar changes in membrane phospholipids during ACTH action on adrenocortical cells, suggest that the turnover of arachidonic acid in phospholipids mediated by a Ca2+-dependent phospholipase A2 may represent a general mechanism for producing rapid perturbations in the cell membrane during accelerated secretory activity.

Submitted on May 19, 1980
Accepted on August 1, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics